Key result
Prehypertension carries minimal CVD mortality risk compared to hypertension.
Why the study?
What is the population attributable fraction of prehypertension on cardiovascular disease mortality in Japanese adults?
Cohort (n=12,928)
What is the population attributable fraction of prehypertension on cardiovascular disease mortality in Japanese adults?
Hazard Ratio: 1.31 (95% CI 0.59–2.94)
Prehypertension accounts for a relatively small fraction of cardiovascular disease mortality compared to hypertension in the Japanese population.
Reinforces hypertension as primary target for CV mortality reduction; leaves open prehypertension's role in middle-aged adults.
BACKGROUND: Although relative risk of prehypertension (pre-HT) on cardiovascular disease (CVD) mortality is modest, prevalence of pre-HT is large, that is, population attributable fraction (PAF) of pre-HT on CVD mortality might be large. However, no studies have reported the fraction. METHODS: We followed 12,928 Japanese National Health Insurance (NHI) beneficiaries aged 40-79 years without a history of CVD. On the basis of their blood pressure (BP), the participants were categorized as normal BP, pre-HT, and hypertension (HT) (Seventh Report of the Joint National Committee criteria). Multivariate-adjusted Cox proportional hazards model was used to estimate the hazard ratio (HR) of the BP status vs. CVD mortality. RESULTS: During 12-years of follow-up, 321 participants died of CVD. As positive relation between BP category and CVD mortality was steeper in middle-aged (40-64 years) than that in elderly (65-79 years), we separately calculated PAF on CVD mortality among middle-aged and elderly. HR (95% confidence interval) for cardiovascular mortality for pre-HT and HT, respectively, was 1.31 (0.59-2.94) and 2.98 (1.39-6.41) in middle-aged, and 1.03 (0.62-1.70) and 1.65 (1.02-2.64) in elderly. Non-normal BP, i.e., pre-HT and HT, accounted for 47 and 26% of the CVD deaths among the middle-aged and elderly participants, respectively. Although the PAF of pre-HT was larger in the middle-aged participants (7%) than that in the elderly ones (0%), neither fraction was considered large. CONCLUSION: The PAF on CVD mortality in pre-HT was not large compared with that in HT.
No takes yet. Share an insight, caveat, or question.
Hozawa et al. (2008) conducted a cohort in Prehypertension (n=12,928). Prehypertension vs. Normal blood pressure was evaluated on Cardiovascular disease mortality (HR 1.31, 95% CI 0.59-2.94). Prehypertension accounted for a small population attributable fraction of cardiovascular mortality (7% in middle-aged and 0% in elderly adults) compared to hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: